| Filed On | Filing |
|---|---|
| 10 Nov 2026 |
8-K: Results of Operations and Financial Condition
KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA |
| 14 Aug 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
This Amendment No. 1 (this “Amendment”) to the Amended and Restated By-laws of KORU Medical Systems, Inc. effective February 5, 2026 (the “By-laws”) is made as of August 13, 2026 in accordance with Section 8.02 of the By-laws. Capitalize... |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition
MAHWAH, NJ – August 5, 2026 – KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-ce... |
| 30 Jun 2026 |
8-K: Entry into a Material Definitive Agreement
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED, AND THE EXCLUDED TERMS HAVE BEEN MARKED AT THE APPROPRIATE PLACE WITH TH... |
| 21 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Set forth below are the voting results from the 2026 Annual Meeting of Shareholders held on May 19, 2026: |
| 06 May 2026 |
8-K: Results of Operations and Financial Condition
MAHWAH, NJ – May 6, 2026 – KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centr... |
| 03 Apr 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
This Amendment No. 3 to Loan and Security Agreement (this “Amendment”) is entered into as of March 30, 2026 by and between (a) KORU MEDICAL SYSTEMS, INC., a Delaware corporation (“Borrower”) and (b) HSBC Ventures USA Inc. (the “Bank”) wi... |
| 16 Mar 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is made by and between KORU Medical Systems, Inc., a Delaware corporation, having its principal place of business at 100 Corporate Drive, Mahwah, NJ 07430 (the “Company”),... |
| 12 Mar 2026 |
8-K: Results of Operations and Financial Condition
KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance |
| 11 Feb 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
Section 1.01 Registered Office. The registered office of Koru Medical Systems, Inc. (the “Corporation”) will be fixed in the Certificate of Incorporation of the Corporation (the “Certificate of Incorporation”). |
| 12 Jan 2026 |
8-K: Results of Operations and Financial Condition
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow |
| 25 Nov 2025 |
8-K: Entry into a Material Definitive Agreement
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED, AND THE EXCLUDED TERMS HAVE BEEN MARKED AT THE APPROPRIATE PLACE WITH TH... |
| 12 Nov 2025 |
8-K: Results of Operations and Financial Condition
MAHWAH, NJ – November 12, 2025 – KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-cen... |
| 06 Aug 2025 |
8-K: Results of Operations and Financial Condition
KORU MEDICAL SYSTEMS ANNOUNCES Q2 2025 FINANCIAL RESULTS, INCLUDING RECORD DOUBLE-DIGIT REVENUE, AND RAISES 2025 REVENUE GUIDANCE |
| 15 May 2025 |
8-K: Submission of Matters to a Vote of Security Holders
Set forth below are the voting results from the 2025 Annual Meeting of Shareholders held on May 14, 2025: |
| 07 May 2025 |
8-K: Results of Operations and Financial Condition
MAHWAH, NJ – May 7, 2025 – KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric l... |
| 07 Apr 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
On April 3, 2025, Kenneth Miller resigned his employment and position as Chief Commercial Officer of KORU Medical Systems, Inc. (the “Company”), effective immediately, to pursue a Chief Executive Officer role at an organization that does... |
| 04 Apr 2025 |
8-K: Entry into a Material Definitive Agreement
This Amendment No. 1 to Loan and Security Agreement (this “Amendment”) is dated as of March 31, 2025, by and between KORU MEDICAL SYSTEMS, INC., a Delaware corporation (“Borrower”) and HSBC VENTURES USA INC., a Delaware corporation (“Ban... |
| 12 Mar 2025 |
8-K: Results of Operations and Financial Condition
KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results with Record Revenues and Gross Profit; Issues Full Year 2025 Guidance |
| 13 Jan 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results;Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter |
Loading...